Decoding the transcriptional programs activated by psychotropic drugs in the brain

Area of Science:

• Neuroscience
• Pharmacology
• Genomics

Background:

• Analyzing drug-induced gene expression in the brain is crucial for understanding drug actions and predicting clinical outcomes.
• Despite progress, robust prediction of psychoactive compound properties from gene expression profiles remains a challenge.

Purpose of the Study:

• To provide an overview of current understanding of drug-induced gene expression in the brain.
• To identify obstacles in predicting psychoactive compound properties using gene expression profiles.
• To explore the potential of gene expression signatures for drug classification and screening.

Main Methods:

• Comprehensive review of mechanisms controlling drug-inducible transcription, including noncoding RNAs and alternative gene isoforms.
• Analysis of studies examining associations within drug classes regarding gene transcription effects, cell signaling, and neuropharmacological properties.
• Evaluation of the utility of gene expression signatures for distinguishing drug classes and predicting drug properties.

Main Results:

• The complexity of gene expression regulation, including noncoding RNAs and alternative isoforms, presents challenges.
• While distinguishing specific drug classes by gene expression signatures is unclear, some studies show predictive capabilities under specific conditions.
• Gene expression signatures show potential for classifying psychotropic drugs and screening novel psychoactive compounds.

Conclusions:

• Integrating exponentially growing high-throughput data sets is key for future advances in understanding drug-induced brain gene expression.
• Gene expression signatures offer a promising, albeit constrained, approach for classifying and screening psychoactive compounds.
• Overcoming obstacles in gene expression analysis is vital for realizing the full potential of predicting drug efficacy and mechanisms.